Juneja Deven, Kataria Sahil
Department ofCritical Care Medicine, Max Super Speciality Hospital, Delhi 110017, India.
World J Clin Cases. 2022 May 6;10(13):4324-4326. doi: 10.12998/wjcc.v10.i13.4324.
Capillary leak syndrome (CLS) is a rare clinical syndrome associated with significant morbidity and mortality. Intensive care and supportive therapy constitute the mainstay of the treatment, along with judicious use of crystalloids and colloids such as dextran and starch during the leak phase. The advantages of proning, steroids, and intravenous immunoglobins are worth contemplating in patients with such a presentation. Extracorporeal membrane oxygenation appears to be an excellent strategy to surmount the impediments of the leak and post leak phase of CLS, especially in patients with severe or refractory hypoxemia.
毛细血管渗漏综合征(CLS)是一种罕见的临床综合征,具有较高的发病率和死亡率。重症监护和支持性治疗是主要治疗手段,同时在渗漏期谨慎使用晶体液和胶体液,如右旋糖酐和淀粉。对于出现这种症状的患者,俯卧位、使用类固醇和静脉注射免疫球蛋白的益处值得考虑。体外膜肺氧合似乎是克服CLS渗漏期和渗漏后期障碍的极佳策略,尤其是对于严重或难治性低氧血症患者。